Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Wittayer

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Magnetic Resonance Imaging|March 27, 2021
Quantitative MRI texture analysis in chronic active multiple sclerosis lesionsClaudia E Weber, Matthias Wittayer, Matthias Kraemer, et al.
Magnetic Resonance Imaging|October 21, 2022
Exploring (peri-) lesional and structural connectivity tissue damage through T1/T2-weighted ratio in iron rim multiple sclerosis lesionsMatthias Wittayer, Claudia E Weber, Julia Krämer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 29, 2023
Cerebrospinal fluid-related tissue damage in multiple sclerosis patients with iron rim lesionsMatthias Wittayer, Claudia E Weber, Maximilian Kittel, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Long-term dynamics of multiple sclerosis iron rim lesionsClaudia E Weber, Matthias Wittayer, Matthias Kraemer, et al.
European Radiology|September 22, 2021
Association of iron rim lesions with brain and cervical cord volume in relapsing multiple sclerosisClaudia E Weber, Julia Krämer, Matthias Wittayer, et al.
European Journal of Pain (London, England)|March 24, 2021
Human surrogate models of central sensitization: A critical review and practical guideCharles Quesada, Anna Kostenko, Idy Ho, et al.
Trials|June 18, 2021
IMI2-PainCare-BioPain-RCT3: a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by electroencephalography (EEG)André Mouraux, Petra Bloms-Funke, Irmgard Boesl, et al.
Trials|September 5, 2022
IMI2-PainCare-BioPain-RCT2 protocol: a randomized, double-blind, placebo-controlled, crossover, multicenter trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by non-invasive neurophysiological measurements of human spinal cord and brainstem activityCaterina Leone, Giulia Di Stefano, Giuseppe Di Pietro, et al.
Anesthesiology|August 4, 2025
The effects of lacosamide, pregabalin, and tapentadol on peripheral nerve excitability: A randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjectsZahra Nochi, Hossein Pia, Petra Bloms-Funke, et al.
Trials|February 20, 2022
IMI2-PainCare-BioPain-RCT1: study protocol for a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by peripheral nerve excitability testing (NET)Zahra Nochi, Hossein Pia, Petra Bloms-Funke, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Magnetic Resonance Imaging|March 27, 2021
Quantitative MRI texture analysis in chronic active multiple sclerosis lesionsClaudia E Weber, Matthias Wittayer, Matthias Kraemer, et al.
Magnetic Resonance Imaging|October 21, 2022
Exploring (peri-) lesional and structural connectivity tissue damage through T1/T2-weighted ratio in iron rim multiple sclerosis lesionsMatthias Wittayer, Claudia E Weber, Julia Krämer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 29, 2023
Cerebrospinal fluid-related tissue damage in multiple sclerosis patients with iron rim lesionsMatthias Wittayer, Claudia E Weber, Maximilian Kittel, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Long-term dynamics of multiple sclerosis iron rim lesionsClaudia E Weber, Matthias Wittayer, Matthias Kraemer, et al.
European Radiology|September 22, 2021
Association of iron rim lesions with brain and cervical cord volume in relapsing multiple sclerosisClaudia E Weber, Julia Krämer, Matthias Wittayer, et al.
European Journal of Pain (London, England)|March 24, 2021
Human surrogate models of central sensitization: A critical review and practical guideCharles Quesada, Anna Kostenko, Idy Ho, et al.
Trials|June 18, 2021
IMI2-PainCare-BioPain-RCT3: a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by electroencephalography (EEG)André Mouraux, Petra Bloms-Funke, Irmgard Boesl, et al.
Trials|September 5, 2022
IMI2-PainCare-BioPain-RCT2 protocol: a randomized, double-blind, placebo-controlled, crossover, multicenter trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by non-invasive neurophysiological measurements of human spinal cord and brainstem activityCaterina Leone, Giulia Di Stefano, Giuseppe Di Pietro, et al.
Anesthesiology|August 4, 2025
The effects of lacosamide, pregabalin, and tapentadol on peripheral nerve excitability: A randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjectsZahra Nochi, Hossein Pia, Petra Bloms-Funke, et al.
Trials|February 20, 2022
IMI2-PainCare-BioPain-RCT1: study protocol for a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by peripheral nerve excitability testing (NET)Zahra Nochi, Hossein Pia, Petra Bloms-Funke, et al.
Pageof 2